U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07359872) titled 'Relaxin Therapy for Atrial Fibrillation' on Jan. 20.
Brief Summary: Atrial fibrillation (AF) is the most common heart rhythm disorder. The presence of AF increases the risk of death and is associated with a 5-6-fold increase in stroke incidence, due almost exclusively to thrombus formation in the heart. Current therapies for AF are limited. The evaluation of new, more effective treatments for preventing AF recurrence remains a critical unmet clinical need. AF is considered a progressive disease that increases in prevalence with age and can convert from "paroxysmal" to "persistent" to "permanent" AF in a single individual. This progr...